Skip to Content
Merck
CN

A6508

L-Aspartic acid β-hydroxamate

>98%

Synonym(s):

AAH, HDX, LAH

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C4H8N2O4
CAS Number:
Molecular Weight:
148.12
UNSPSC Code:
12352209
eCl@ss:
32160406
PubChem Substance ID:
NACRES:
NA.26
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

L-Aspartic acid β-hydroxamate, serine racemase inhibitor

Quality Level

assay

>98%

form

powder

color

white to yellow

application(s)

detection

storage temp.

−20°C

SMILES string

N[C@@H](CC(=O)NO)C(O)=O

InChI

1S/C4H8N2O4/c5-2(4(8)9)1-3(7)6-10/h2,10H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1

InChI key

ZBYVTTSIVDYQSO-REOHCLBHSA-N



Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



N Thomasset et al.
International journal of cancer, 49(3), 421-424 (1991-09-30)
D and L isomers of aspartic acid beta-hydroxamate (respectively DAH and LAH) were compared for their in vitro and in vivo activity against the murine leukemia L5178Y and their tolerance in vivo in DBA/2 mice. DAH and LAH displayed comparable
Daniel Sepúlveda-Crespo et al.
Nanomedicine : nanotechnology, biology, and medicine, 13(1), 49-58 (2016-08-27)
Hepatitis C virus (HCV) infection is a major biomedical problem worldwide. Although new direct antiviral agents (DAAs) have been developed for the treatment of chronic HCV infection, the potential emergence of resistant virus variants and the difficulties to implement their
Noam Nissan et al.
Journal of magnetic resonance imaging : JMRI, 49(2), 508-517 (2018-09-01)
Pregnancy-associated breast cancer (PABC) is often a delayed diagnosis and contrast-enhanced MRI is contraindicated because gadolinium agents are known to cross the placenta. To investigate the feasibility and clinical utility of noncontrast breast MRI using diffusion tensor imaging (DTI) in



Global Trade Item Number

SKUGTIN
A6508-100MG04061832421179
A6508-1G04061833382301